News
March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday. The investment will mark the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback